二尖瓣介入瓣膜现状.pdfVIP

Development of a TMVR Device Challenge to Innovators Eberhard Grube MD, FACC, FSCAI, FAPSIC University Bonn, Heart Center, Bonn, Germany Stanford Universuty, School of Medicine, Palo Alto, CA Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company • Grant/Research Support • Nil • Consulting Fees / Honoraria • Boston Scientific, Medtronic, Valtec Biosensors, Symetis • Minor Stock Shareholder/Equity • M-Valve, Mitralign, Valtec, Twelve, Claret, Shockwave • Royalty Income • Nil • Ownership/Founder • Nil • Intellectual Property Rights • Nil • Other Financial Benefit (Advisory Board, Proctor) • Medtronic, Boston Scientific, Outline • Why are we here? • Innovator’s Challenges in Cardiology • Challenges in Mitral Valve Disease • Differentiate DMR and FMR • Repair vs. Replacement • Brief Parade of Technologies • Additional and Final Thoughts Why Are We Here? Premature? Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ PR Newswire IRVINE, Calif., Aug. 26, 2015 Edwards Lifesciences (EW) Acquires CardiAQ Valve Technologies in $400 IRVINE, Calif., Aug. 26, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the Million Deal science of heart valves and hemodynamic monitoring, t